155 related articles for article (PubMed ID: 21427907)
1. [Expression and its relationship of murine double minute 2 and P53 protein in oral leukoplakia and squamous cell carcinoma].
Han BF; Wu PF; Pan J; Li Y; Li LJ
Hua Xi Kou Qiang Yi Xue Za Zhi; 2011 Feb; 29(1):79-82. PubMed ID: 21427907
[TBL] [Abstract][Full Text] [Related]
2. [Expressions of PDCD5 and p53 in oral leukoplakia and oral squamous cell carcinoma].
Zhao XY; Liu HW; Wei MJ
Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):429-32. PubMed ID: 16086069
[TBL] [Abstract][Full Text] [Related]
3. [Expression of Ki-67 and P53 protein in oral squamous cell carcinoma and its clinical significance].
He W; Xiao Y; Chen WM
Shanghai Kou Qiang Yi Xue; 2015 Apr; 24(2):228-31. PubMed ID: 25938156
[TBL] [Abstract][Full Text] [Related]
4. Mutated and wild-type p53 expression and HPV integration in proliferative verrucous leukoplakia and oral squamous cell carcinoma.
Gopalakrishnan R; Weghorst CM; Lehman TA; Calvert RJ; Bijur G; Sabourin CL; Mallery SR; Schuller DE; Stoner GD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1997 Apr; 83(4):471-7. PubMed ID: 9127380
[TBL] [Abstract][Full Text] [Related]
5. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. p53 and MDM2 expression in oral squamous cell carcinoma.
Matsumura T; Yoshihama Y; Kimura T; Shintani S; Alcalde RE
Oncology; 1996; 53(4):308-12. PubMed ID: 8692535
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
11. p53 mutation and detection of p53 protein expression in oral leukoplakia and oral squamous cell carcinoma.
Ries JC; Schreiner D; Steininger H; Girod SC
Anticancer Res; 1998; 18(3B):2031-6. PubMed ID: 9677462
[TBL] [Abstract][Full Text] [Related]
12. Expression and significance of p53 and mdm2 in patients with leukoplakia cancer.
Cui JJ; Han XL; Wang WM
Asian Pac J Trop Med; 2013 Oct; 6(10):831-4. PubMed ID: 23870475
[TBL] [Abstract][Full Text] [Related]
13. Expression of p53, epidermal growth factor receptor, c-erbB2 in oral leukoplakias and oral squamous cell carcinomas.
Singla S; Singla G; Zaheer S; Rawat DS; Mandal AK
J Cancer Res Ther; 2018; 14(2):388-393. PubMed ID: 29516925
[TBL] [Abstract][Full Text] [Related]
14. [Immunohistochemical analysis of the p53 tumor suppressor gene product in oral leukoplakia].
Kikegawa A
Kokubyo Gakkai Zasshi; 2001 Mar; 68(1):51-9. PubMed ID: 11321806
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical detection of p53 oncoprotein in human oral squamous cell carcinomas and leukoplakias: comparison with proliferating cell nuclear antigen staining and correlation with clinicopathological findings.
Nishioka H; Hiasa Y; Hayashi I; Kitahori Y; Konishi N; Sugimura M
Oncology; 1993; 50(6):426-9. PubMed ID: 7901826
[TBL] [Abstract][Full Text] [Related]
16. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
17. Autophagy analysis in oral carcinogenesis.
de Lima TB; Paz AHR; Rados PV; Leonardi R; Bufo P; Pedicillo MC; Santoro A; Cagiano S; Aquino G; Botti G; Pannone G; Visioli F
Pathol Res Pract; 2017 Sep; 213(9):1072-1077. PubMed ID: 28843750
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of expression of p53 tumor suppressor gene in human oral squamous cell carcinoma].
Okuno-Ishii N
Kokubyo Gakkai Zasshi; 1993 Mar; 60(1):131-48. PubMed ID: 8482898
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
20. [Expression of Prion protein and its clinical significance in oral squamous cells carcinoma and oral leukoplakia].
Zhang J; Zeng Y; Zheng J; Xu J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2013 Dec; 48(12):752-4. PubMed ID: 24495728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
